Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
6(35%)
Results Posted
25%(1 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_1
2
12%
Ph not_applicable
10
59%
Ph phase_2
2
12%
Ph phase_3
1
6%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
2(13.3%)
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
1(6.7%)
N/ANon-phased studies
10(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

6

trials recruiting

Total Trials

17

all time

Status Distribution
Active(9)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
Recruiting4
Not yet recruiting3
unknown2
Active, not recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
6
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (13.3%)
Phase 22 (13.3%)
Phase 31 (6.7%)
N/A10 (66.7%)

Trials by Status

unknown212%
withdrawn16%
completed424%
not_yet_recruiting318%
recruiting424%
active_not_recruiting212%
terminated16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT05081531Not Applicable

AI for Head Neck Cancer Treated With Adaptive RadioTherapy (RadiomicART)

Active Not Recruiting
NCT06108206

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Active Not Recruiting
NCT05833867Phase 1

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Recruiting
NCT05488626Not Applicable

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

Withdrawn
NCT07043543Not Applicable

Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)

Not Yet Recruiting
NCT06492486Phase 2

Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

Not Yet Recruiting
NCT01504815Phase 3

Adaptive Radiation Treatment for Head and Neck Cancer

Completed
NCT06214611Not Applicable

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

Recruiting
NCT06216171Not Applicable

Adaptive Radiotherapy in Head and Neck Tumor Patients

Recruiting
NCT06230549Not Applicable

Adaptive Radiotherapy in Patients With Gynecological Tumors

Recruiting
NCT06201351

Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI

Not Yet Recruiting
NCT03096808Phase 2

Adaptive Radiotherapy for Head and Neck Cancer

Completed
NCT04242459Phase 1

Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers

Unknown
NCT01762527Not Applicable

Adaptive Radiotherapy Using Plan Selection for Bladder Cancer

Completed
NCT00490282Not Applicable

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Completed
NCT04022018Not Applicable

Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence

Unknown
NCT01647334Not Applicable

Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Terminated

All 17 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
17